Comparison of two kind of drug oral and subcutaneous in prevention of deep vein ?thrombosis in patients admitted to intensive care unit

Phase 3

• Conditions: Thromboembolism.; Embolism and thrombosis of unspecified artery; O88.23

• Registration Number: IRCT20141209020258N140
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 18 May 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 98

Inclusion Criteria

Ages 18 to 60 years
Possibility to gavage or start oral feeding
Glomerular filtration above 50%
Patients hospitalized in intensive care units

Exclusion Criteria

Contraindications to anti-coagulant
Allergy to Rivaroxaban

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence of thromboembolism. Timepoint: After the end of treatment. Method of measurement: Physical examination.